相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras
Ki-Hyuk Shin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The Evi1, microRNA-143, K-Ras axis in colon cancer
Jin-Song Gao et al.
FEBS LETTERS (2011)
Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability
Feijun Luo et al.
JOURNAL OF PATHOLOGY (2011)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
Amplification of the Driving Oncogene, KRAS or BRAF, Underpins Acquired Resistance to MEK1/2 Inhibitors in Colorectal Cancer Cells
Annette S. Little et al.
SCIENCE SIGNALING (2011)
Ubiquitination of K-Ras Enhances Activation and Facilitates Binding to Select Downstream Effectors
Atsuo T. Sasaki et al.
SCIENCE SIGNALING (2011)
Therapeutic modulation of k-ras signaling in colorectal cancer
Lisanne L. Krens et al.
DRUG DISCOVERY TODAY (2010)
The KRAS Promoter Responds to Myc-associated Zinc Finger and Poly(ADP-ribose) Polymerase 1 Proteins, Which Recognize a Critical Quadruplex-forming GA-element
Susanna Cogoi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models
Silvestre Vicent et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Prognostic relevance of DNA copy number changes in colorectal cancer
George Poulogiannis et al.
JOURNAL OF PATHOLOGY (2010)
K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation
Feijun Luo et al.
JOURNAL OF PATHOLOGY (2010)
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Wendy De Roock et al.
LANCET ONCOLOGY (2010)
A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth
Hiroaki Mita et al.
BMC CANCER (2009)
The miR-18a*microRNA functions as a potential tumor suppressor by targeting on K-Ras
Wing Pui Tsang et al.
CARCINOGENESIS (2009)
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
Claudia Scholl et al.
CELL (2009)
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
Ji Luo et al.
CELL (2009)
Mutated K-rasAsp12 promotes tumourigenesis in ApcMin mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways
Feijun Luo et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma
Jehad Abubaker et al.
JOURNAL OF PATHOLOGY (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
Anthony J. Muslin
CLINICAL SCIENCE (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
Helena Linardou et al.
LANCET ONCOLOGY (2008)
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
Kevin M. Haigis et al.
NATURE GENETICS (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Suppression of non-small cell lung tumor development by the let-7 microRNA family
Madhu S. Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers
Sabrina Arena et al.
CANCER RESEARCH (2007)
Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice
F. Luo et al.
ONCOGENE (2007)
Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo
Owen J. Sansom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species
Suma Ray et al.
CANCER RESEARCH (2006)
let-7 microRNA functions as a potential growth suppressor in human colon cancer cells
Yukihiro Akao et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis
TG Bivona et al.
MOLECULAR CELL (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
RAS is regulated by the let-7 MicroRNA family
SM Johnson et al.
CELL (2005)
A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer
J Lamb et al.
CELL (2003)
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
C Guerra et al.
CANCER CELL (2003)
Mitogen-activated protein kinases:: A new therapeutic target in cardiac pathology
T Ravingerová et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice
KP Janssen et al.
GASTROENTEROLOGY (2002)
c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability
O Vafa et al.
MOLECULAR CELL (2002)
E2F1 and c-Myc potentiate apoptosis through inhibition of NF-κB activity that facilitates MnSOD-mediated ROS elimination
H Tanaka et al.
MOLECULAR CELL (2002)
Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study
HJN Andreyev et al.
BRITISH JOURNAL OF CANCER (2001)
The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway
HI Saavedra et al.
ONCOGENE (2000)
分享论文
